BriaCell Therapeutics Corp. (BCT.TO)
CAD 0.87
(-4.4%)
CAD 0.87
(-4.4%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.74 USD | -73.33% |
| 2022 | -0.75 USD | -294.74% |
| 2021 | -0.19 USD | -109.79% |
| 2020 | 1.94 CAD | 86.54% |
| 2019 | 1.04 CAD | -58.23% |
| 2018 | 2.49 CAD | 132.72% |
| 2017 | -7.61 CAD | -29.42% |
| 2016 | -5.88 CAD | 45.35% |
| 2015 | -10.76 CAD | 92.21% |
| 2014 | -138.07 CAD | -2109.12% |
| 2013 | -6.25 CAD | 63.08% |
| 2012 | -16.93 CAD | 48.73% |
| 2011 | -33.02 CAD | 33.4% |
| 2010 | -49.58 CAD | -93.52% |
| 2009 | -25.62 CAD | -25.28% |
| 2008 | -20.45 CAD | 26.76% |
| 2007 | -27.92 CAD | -567.94% |
| 2006 | -4.18 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 0.11 USD | 115.49% |
| 2024 Q1 | 0.38 USD | 100.25% |
| 2024 Q2 | -0.71 USD | -286.84% |
| 2024 Q4 | -0.07 USD | -161.27% |
| 2023 Q4 | -154.27 USD | -54996.43% |
| 2023 FY | - USD | -73.33% |
| 2023 Q3 | -0.28 USD | 83.82% |
| 2023 Q2 | -1.73 USD | -923.81% |
| 2023 Q1 | 0.21 USD | 111.11% |
| 2022 Q2 | 0.71 USD | 1124.14% |
| 2022 Q4 | -1.89 USD | -1360.0% |
| 2022 FY | - USD | -294.74% |
| 2022 Q3 | 0.15 USD | -78.87% |
| 2022 Q1 | 0.06 USD | 132.22% |
| 2021 Q3 | 0.49 CAD | 1440.88% |
| 2021 FY | - USD | -109.79% |
| 2021 Q1 | 0.30 CAD | 137.04% |
| 2021 Q4 | -0.18 USD | -136.73% |
| 2021 Q2 | 0.03 CAD | -89.4% |
| 2020 Q4 | -0.81 CAD | -297.56% |
| 2020 Q3 | 0.41 CAD | -40.58% |
| 2020 Q2 | 0.69 CAD | 18.97% |
| 2020 Q1 | 0.58 CAD | 129.44% |
| 2020 FY | - CAD | 86.54% |
| 2019 Q1 | -1.48 CAD | 50.83% |
| 2019 Q3 | 0.43 CAD | 119.46% |
| 2019 Q2 | -2.21 CAD | -49.32% |
| 2019 Q4 | -1.97 CAD | -558.14% |
| 2019 FY | - CAD | -58.23% |
| 2018 Q2 | -2.12 CAD | -57.04% |
| 2018 FY | - CAD | 132.72% |
| 2018 Q4 | -3.01 CAD | -22.86% |
| 2018 Q3 | -2.45 CAD | -15.57% |
| 2018 Q1 | -1.35 CAD | 56.17% |
| 2017 Q1 | -1.07 CAD | -37.18% |
| 2017 Q4 | -3.08 CAD | -22.22% |
| 2017 Q3 | -2.52 CAD | -165.26% |
| 2017 FY | - CAD | -29.42% |
| 2017 Q2 | -0.95 CAD | 11.21% |
| 2016 Q3 | -1.20 CAD | 52.57% |
| 2016 Q2 | -2.53 CAD | -132.11% |
| 2016 Q1 | -1.09 CAD | -240.63% |
| 2016 Q4 | -0.78 CAD | 35.0% |
| 2016 FY | - CAD | 45.35% |
| 2015 Q1 | -0.66 CAD | 99.47% |
| 2015 Q4 | -0.32 CAD | 76.64% |
| 2015 Q2 | -10.27 CAD | -1456.06% |
| 2015 FY | - CAD | 92.21% |
| 2015 Q3 | -1.37 CAD | 86.66% |
| 2014 Q3 | -9.12 CAD | -575.56% |
| 2014 Q2 | -1.35 CAD | 47.47% |
| 2014 Q1 | -2.57 CAD | -57.67% |
| 2014 FY | - CAD | -2109.12% |
| 2014 Q4 | -125.10 CAD | -1271.71% |
| 2013 Q3 | -1.88 CAD | -30.56% |
| 2013 FY | - CAD | 63.08% |
| 2013 Q1 | -1.33 CAD | 84.17% |
| 2013 Q4 | -1.63 CAD | 13.3% |
| 2013 Q2 | -1.44 CAD | -8.27% |
| 2012 Q3 | -6.37 CAD | -3452.63% |
| 2012 Q2 | 0.19 CAD | 108.26% |
| 2012 Q1 | -2.30 CAD | 74.64% |
| 2012 FY | - CAD | 48.73% |
| 2012 Q4 | -8.40 CAD | -31.87% |
| 2011 Q3 | -9.48 CAD | -21.85% |
| 2011 Q1 | -4.55 CAD | 66.54% |
| 2011 Q2 | -7.78 CAD | -70.99% |
| 2011 Q4 | -9.07 CAD | 4.32% |
| 2011 FY | - CAD | 33.4% |
| 2010 Q3 | -27.19 CAD | -747.04% |
| 2010 Q2 | -3.21 CAD | 9.83% |
| 2010 Q1 | -3.56 CAD | 58.75% |
| 2010 FY | - CAD | -93.52% |
| 2010 Q4 | -13.60 CAD | 49.98% |
| 2009 Q3 | -1.40 CAD | 79.8% |
| 2009 Q4 | -8.63 CAD | -516.43% |
| 2009 Q1 | -8.99 CAD | 11.34% |
| 2009 FY | - CAD | -25.28% |
| 2009 Q2 | -6.93 CAD | 22.91% |
| 2008 Q1 | -0.79 CAD | 88.12% |
| 2008 Q3 | -5.02 CAD | -45.09% |
| 2008 Q4 | -10.14 CAD | -101.99% |
| 2008 FY | - CAD | 26.76% |
| 2008 Q2 | -3.46 CAD | -337.97% |
| 2007 Q3 | -1.22 CAD | 85.42% |
| 2007 FY | - CAD | -567.94% |
| 2007 Q4 | -6.65 CAD | -445.08% |
| 2007 Q2 | -8.37 CAD | -68.75% |
| 2007 Q1 | -4.96 CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Appili Therapeutics Inc. | -0.03 CAD | -5476.923% |
| Eupraxia Pharmaceuticals Inc. | -1.58 CAD | -10.127% |
| Helix BioPharma Corp. | -0.21 CAD | -728.571% |
| Microbix Biosystems Inc. | -0.00 CAD | -579900.0% |
| Medicenna Therapeutics Corp. | -0.37 CAD | -370.27% |
| Satellos Bioscience Inc. | -0.18 CAD | -866.667% |
| Oncolytics Biotech Inc. | -0.41 CAD | -324.39% |
| Sernova Corp. | -0.13 CAD | -1238.462% |